Key safety monitoring parameters include: Baseline and periodic assessment of nutritional status (complete blood count, comprehensive metabolic panel, vitamin levels, albumin) Renal function monitoring, particularly during dose escalation, due to risk of acute kidney injury from dehydration Evaluation for gastrointestinal symptoms and differentiation from surgical complications Monitoring for gallbladder disease, which may be increased with weight loss and semaglutide use Assessment of medication adherence and injection technique Eye examination in patients with diabetes due to potential risk of diabetic retinopathy progression with rapid glycemic improvement Regular follow-up with both bariatric surgery and endocrinology or obesity medicine teams when possible Patients should be counseled to report severe or persistent nausea, vomiting, abdominal pain, or inability to maintain adequate hydration or nutrition, as these may warrant dose adjustment, temporary discontinuation, or further evaluation for surgical complications
But our attorneys are here to help you find justice in the legal system
Weeks 912: Second increase (~8mg weekly)
Many patients tolerate and benefit from: bone broth and mineral-rich soups softly cooked vegetables that are easy to digest high-quality proteins such as organic poultry, fish, eggs, or slow-cooked meats healthy fats in modest amounts to support healing These foods provide nourishment without overwhelming digestion and can often be consumed even when appetite is limited
